title: Pirfenidone inhibits early neointimal proliferation following arterial injury.
authors.affiliation: Division of Transplant Surgery, Royal College of Surgeons of England, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK. julian@waller79.fsnet.co.uk
authors.forename: Julian R
authors.initials: JR
authors.lastname: Waller
authors.forename: D
authors.initials: D
authors.lastname: Toomey
authors.forename: M S
authors.initials: MS
authors.lastname: Metcalfe
authors.forename: S B
authors.initials: SB
authors.lastname: Margolin
authors.forename: M L
authors.initials: ML
authors.lastname: Nicholson
mesh_terms: D000821:Animal Feed; D000818:Animals; D002455:Cell Division; D019587:Dietary Supplements; D006965:Hyperplasia; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology*; D011183:Postoperative Complications / Q000473:pathology / Q000517:prevention & control; D011728:Pyridones / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D017539:Tunica Intima / Q000187:drug effects / Q000473:pathology*; D014652:Vascular Diseases / Q000473:pathology / Q000517:prevention & control*
chemical_list: D011728:Pyridones; D014409:Tumor Necrosis Factor-alpha; C093844:pirfenidone